Fructose-1,6-bisphosphate reduces the mortality in candida albicans bloodstream infection and prevents the septic-induced platelet decrease

Inflammation

Volumn 35, Issue 4, 2012, Pages 1256-1261

  Santos, Roberto Christ Vianna ^a,b,c   Moresco, Rafael Noal ^d   Rico, Miguel Angel Pena ^c   Susperregui, Antonio R García ^c   Rosa, Jose Luis ^c   Bartrons, Ramon ^c   Ventura, Francesc ^c   Mário, Débora Nunes ^d   Alves, Sydney Hartz ^d   Tatsch, Etiane ^d   Kober, Helena ^d   De Mello, Ricardo Obalski ^a   Scherer, Patrícia ^b   Dias, Henrique Bregolin ^b   De Oliveira, Jarbas Rodrigues ^b,c  

^a CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF BARCELONA   (Spain)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Candidemia; IL 6; MCP 1; Sepsis

Indexed keywords

FRUCTOSE 1,6 BISPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD EXAMINATION; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HEMATOLOGICAL PARAMETERS; MALE; MORTALITY; MOUSE; NONHUMAN; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANIMALS; CANDIDA ALBICANS; CANDIDEMIA; CHEMOKINE CCL2; FRUCTOSEDIPHOSPHATES; INTERLEUKIN-6; MALE; MICE; PLATELET COUNT;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; MUS;

EID: 84866730322     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9436-7     Document Type: Article

References (28)

1. Lamagni, T.L., B.G. Evans, M. Shigematsu, and E.M. Johnson. 2001. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiology and Infection 126: 397-414.
2. Eloy, O., V. Blanc, P. Pina, A. Gaudart, M.L. Bressole, C. Plainvert, et al. 2006. Epidemiology of candidemia: Results of a one month French hospitals-based surveillance study in 2004. Pathologie Biologie 54: 523-530.
3. Wisplinghoff, H., T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 39: 309-317.
4. Martin, G.S., D.M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348: 1546-1554.
5. Xu, K., and J.L. Stringer. 2008. Pharmacokinetics of fructose-1,6- diphosphate after intraperitoneal and oral administration to adult rats. Pharmacological Research 57: 234-238.
6. Yin, H., X.B. Jin, Q. Gong, H. Yang, H. Li, F.L. Gong, et al. 2008. Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 20: 1842-1847.
7. Lopes, R.P., A. Lunardelli, T. Preissler, C.E. Leite, J.C.F. Alves-Filho, F.B. Nunes, et al. 2006. The effects of fructose-1,6-bisphosphate and dexamethasone on acute inflammation and Tcell proliferation. Inflammation Research 55: 354-358.
8. Nunes, F.B., J.C.F. Alves-Filho, C.M. Alves Bastos, P.M. Tessele, E. Caberlon, K.B. Moreira, et al. 2004. Effect of the chlorpropamide and fructose-1,6-bisphosphate of soluble TNF receptor II levels. Pharmacological Research 49: 449-453.
9. Alves-Filho, J.C., R.C. Santos, T.A. Castaman, and J.R. Oliveira. 2004. Anti-inflammatory effects of fructose-1,6-bisphosphate on carrageenan-induced pleurisy in rat. Pharmacological Research 49: 245-248.
10. Nunes, F.B., M.G. Simões Pires, J.C.F. Alves-Filho, P.H. Wachter, and J.R. Oliveira. 2002. Physiopathological studies in septic rats and the use of fructose 1,6-bisphosphate as cellular protection. Critical Care Medicine 30: 2069-2074.
11. Nunes, F.B., C.M. Graziottin, J.C.F. Alves-Filho, P.H. Wachter, and J.R. Oliveira. 2003. An assessment of fructose-1,6-bisphosphate as an antimicrobial and anti-inflammatory agent in sepsis. Pharmacological Research 47: 35-44.
12. Levi, M. 2008. The coagulant response in sepsis. Clinics in Chest Medicine 29: 627-642.
13. Remick, D.G., G. Bolgos, S. Copeland, and J. Siddiqui. 2005. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infection and Immunity 5: 2751-2757.
14. Nunes, F.B., P.B. Gaspareto, R.C.V. Santos, M. de Assis, C.M. Graziottin, V. Biolchi, et al. 2003. Intravenous toxicity of fructose-1,6-bisphosphate in rats. Toxicology Letters 143(1): 73-81.
15. Papadimitriou, J.M., and R.B. Ashman. 1986. The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. The Journal of Pathology 150: 257-265.
16. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti, and F. Bistoni. 1993. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. Journal of Immunology 150: 925-931.
17. Hurley, R. 1996. Effect of route of entry of Candida albicans on the histogenis of the lesions in experimental candidosis in the mouse. Journal of Pathology and Bacteriology 92: 578-583.
18. Nuget, K.M., and J.M. Onofrio. 1983. Pulmonary tissue resistance to Candida albicans in normal and immunosuppressed mice. American Review of Respiratory Disease 128: 909-914.
19. Sawyer, R.T. 1990. Experimental pulmonary candidiasis. Mycopathologia 109: 99-109.
20. Fallon, K., K. Bausch, J. Noonan, E. Huguenel, and P. Tamburini. 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infection and Immunity 65: 551-556.
21. de Mello, R.O., A. Lunardelli, E. Caberlon, C.M. de Moraes, R. Christ Vianna Santos, V.L. da Costa, et al. 2010. Effect of Nacetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis. Inflamm. doi:10.1007/s10753-010-9261-9.
22. Oliveira, L.M., M.G.S. Pires, A.B. Magrisso, T.P. Munhoz, R. Roesler, and J.R. Oliveira. 2010. Fructose-1, 6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats. Journal of Thrombosis and Thrombolysis 29: 387-394.
23. Hechler, B., C. Léon, C. Vial, P. Vigne, C. Frelin, J.P. Cazenave, et al. 1998. The P2Y1 receptor is necessary for adenosine 5'-diphosphate- induced platelet aggregation. Blood 92(1): 152-159.
24. Cavallini, L., R. Deana, M.A. Francesconi, and A. Alexandre. 1992. Fructose-1,6-diphosphate inhibits platelet activation. Biochemical Pharmacology 43(7): 1539-1544.
25. Levi, M., E. Jonge, and T. Van Der Poll. 2003. Sepsis and disseminated intravascular coagulation. Journal of Thrombosis and Thrombolysis 16(1-2): 43-47.
26. Biswas, P., F. Delfanti, S. Bernasconi, M. Mengozzi, M. Cota, N. Polentarutti, et al. 1998. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91(1): 258-265.
27. Sola, A., J. Panes, C. Xaus, and G. Hotter. 2003. Fructose-1,6- biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. Journal of Leukocyte Biology 73: 74-81.
28. Yin, H., X.B. Jin, Q. Gong, H. Yang, L.Y. Hu, F.L. Gong, et al. 2008. Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 8(13-14): 1842-1847.